Capitainer enables patients to collect their own volume-defined dried blood spot at home. Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitainer offers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.

International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ.

Newsouth Innovations Pty Ltd., a subsidiary of The University of New South Wales, is an Australian company located in Sydney. The firm provides support services for university of new south wales inventors turn their discoveries into innovations. It was founded in 1959. Kevin Cullen is the CEO, in this role since 2011.

Manufactures and distributes in vitro diagnostics instruments for use in hospital laboratories

DONGKOOK Pharm. Co. Ltd. constructed the prefilled syringe system in its second factory (located at Kwanghyewon-myeon, Jincheon-gun, Chungbuk) for the first time in Asia and produced a large amount of various kinds of ultramodern injection agents. Located on its site are its central research institute, raw material factory, etc. where the raw materials of its main products are extracted and synthesized directly. Also, its third factory completed in 1994 is equipped with ultramodern facilities and is by no means inferior to other factories as the base of a leading company in a new millennium. Particularly, DONGKOOK invests more than 5% of the annual sale for research and development expenses while operating its central research institute centered on holders of master’s degree and PhD.

A. Nattermann & Cie. GmbH engages in the production of over-the-counter and consumer health care drugs. Its products are sold to distribution firms of the Sanofi group. The company is headquartered in Cologne, Germany.

Jiangsu Aosaikang Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical chemicals and health-care products. It offers antibiotics and injections for the digestive, oncology, cardiovascular, and others. The company was founded on January 14, 2003 and is headquartered in Nanjing, China.

Shenzhen Wanle Pharmaceutical Co., Ltd., established on 1990-07-04, Business scope includes general business items:,The licensing program is:to develop,Research,Production and operation of raw materials,small volume injection(Contains anti-tumor),Freeze-dried powder injection(Contains anti-tumor),tablet,Capsules(contain anti-tumor),Imported medicines are packaged separately(tablet),Accessories(Polyethylene glycol monomethyl ether-polylactic acid block copolymer),Goods and technology import and export business.

Kode Biotech Limited is a private New Zealand company established in 1996 to commercialise and license Kode™ Technology.Kode Biotech Ltd is the licensor of existing, and developer of new Kode™ Technology.Vision: Change the surface of biotechnologyMission: Ignite a revolution with Kode™ surface modification nanotechnology by enabling our partners to enhance existing and create next generation products with a technology to shape life.Kode Biotech is the holder and parent of a number of subsidiary companies that licenses Kode™ Technology for various sectors and uses.

Lamellar Biomedical Ltd. manufactures basic pharmaceutical products. The firm's offers lamellasomes, a synthetic substance that mimics the actions lamellar bodies and provides treatment for respiratory diseases, such as cystic fibrosis. The company was founded in 2006 and is headquartered in Bellshill, the United Kingdom.

Part of Halozyme Therapeutics, Inc., Halozyme, Inc. is an American company located in San Diego, CA, focused on biological products, except diagnostic substances.

Shangying Dongying (Jiangsu) Pharmaceutical Co., Ltd. is a direct enterprise of Shanghai Pharmaceutical Group (601607.SH, 02607.HK), specializing in the research and development and manufacture of drugs for the treatment of anesthesia and cardiovascular.

Beijing Zhongke Zhuoming Biomedical Research Institute Co., Ltd., established on 2015-10-20, The scope of business includes the sale of food;wholesale medicine,retail medicine;Medical Research and Experimental Development,Natural science research and experimental development,Engineering and Technology Research and Experimental Development;technology development,technology transfer,technical consulting,Technology Promotion,Technical Services;Technical testing;Sales of daily necessities,biological reagent(Free of Hazardous Chemicals,Does not contain drugs),Chemical Products(Free of Hazardous Chemicals),computer,Software and Auxiliary Equipment,Equipment,cosmetic,medical instruments(limitIkind),Glass product,Instrumentation,rubber products,plastic products,Wujinjiaodian,laboratory equipment,furniture;software development;computer system integration;data processing(onlyPUEvalue in1.5the following);Commissioned processing of chemical products(Free of Hazardous Chemicals);Import and export,Technology Import and Export,Agent import and export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,wholesale medicine,Retail pharmaceuticals and items subject to legal approval,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Hainan MeilanShiKline Pharmaceutical Co., Ltd., established on 2002-01-24, Business scope includes licensed projects:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Class III medical device business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General project:Non-residential real estate leases;property management(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Hainan Yongtian Pharmaceutical Research Institute Co., Ltd., established on 2009-07-28, Business scope includes pharmaceutical product research and development and technology transfer consulting services,Packaging Materials,Instrumentation,chemical reagent,glassware,cosmetic,Chemical raw materials(Except for franchise)promotion of.(General operating items self-management,Licensed business projects are operated on the basis of relevant licenses or approval documents)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Chongqing No. 3 People's Hospital is a private company headquartered in Chongqing, China, that owns and operates hospital.

KOSÉ specializes mainly in the manufacturing and marketing of cosmetics. Its strength lies in its unique and high-value exclusive cosmetics. It aims to offer original and valuable products in all of its brand categories, particularly in the high-prestige and prestige brands, which are characterized by high added value, as well as the cosmetaries* brands, which offer inexpensive and affordable products, mainly in the self-service category. It also offers through various sales channels highly original brands with a wide variety of features to precisely meet the diverse needs of customers. Its brands are divided into two major categories: the KOSÉ brand, a brand that has the company’s name on it, and the individual brands, which represent a wide variety of highly original brands. It was founded in 1946 and is located in Nihonbashi, Tokyo, Japan.